According to Perrigo's latest financial reports the company has $4.76 B in net assets.
A companyโs net assets is the sum of its assets minus the sum of its liabilities.
Year | Net assets | Change |
---|---|---|
2023-12-31 | $4.76 B | -1.53% |
2022-12-31 | $4.84 B | -6.01% |
2021-12-31 | $5.15 B | -8.9% |
2020-12-31 | $5.65 B | -2.57% |
2019-12-31 | $5.80 B | 2.4% |
2018-12-31 | $5.66 B | -8.14% |
2017-12-31 | $6.17 B | 3.58% |
2016-12-31 | $5.95 B | |
2015-06-30 | $10.69 B | 23.07% |
2014-06-30 | $8.69 B | 272.7% |
2013-06-30 | $2.33 B | 25.91% |
2012-06-30 | $1.85 B | 21.01% |
2011-06-30 | $1.53 B | 39.95% |
2010-06-30 | $1.09 B | 18.59% |
2009-06-30 | $0.92 B | -1.2% |
2008-06-30 | $0.93 B | 23.76% |
2007-06-30 | $0.75 B | 17.75% |
2006-06-30 | $0.64 B | 8.45% |
2005-06-30 | $0.59 B | 10.18% |
2004-06-30 | $0.53 B | 19.58% |
2003-06-30 | $0.44 B | 7.24% |
2002-06-30 | $0.41 B | 8.37% |
2001-06-30 | $0.38 B |
Company | Net assets | differencediff. | Country |
---|---|---|---|
United Therapeutics UTHR | $5.98 B | 25.52% | ๐บ๐ธ USA |
Endo International
ENDPQ | -$6.6 B | -238.37% | ๐ฎ๐ช Ireland |
Intercept Pharmaceuticals
ICPT | $71.84 M | -98.49% | ๐บ๐ธ USA |
Catalent CTLT | $3.68 B | -22.67% | ๐บ๐ธ USA |